21.25
price up icon1.46%   0.2895
 
loading
Schlusskurs vom Vortag:
$20.96
Offen:
$20.96
24-Stunden-Volumen:
206.49K
Relative Volume:
0.26
Marktkapitalisierung:
$1.59B
Einnahmen:
$384.03M
Nettoeinkommen (Verlust:
$38.65M
KGV:
68.55
EPS:
0.31
Netto-Cashflow:
$196.35M
1W Leistung:
-3.20%
1M Leistung:
+20.08%
6M Leistung:
+12.11%
1J Leistung:
+11.05%
1-Tages-Spanne:
Value
$20.96
$21.49
1-Wochen-Bereich:
Value
$20.68
$22.48
52-Wochen-Spanne:
Value
$16.52
$22.76

Innoviva Inc Stock (INVA) Company Profile

Name
Firmenname
Innoviva Inc
Name
Telefon
(650) 238-9600
Name
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Name
Mitarbeiter
127
Name
Twitter
Name
Nächster Verdiensttermin
2025-10-31
Name
Neueste SEC-Einreichungen
Name
INVA's Discussions on Twitter

Vergleichen Sie INVA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INVA
Innoviva Inc
21.25 1.57B 384.03M 38.65M 196.35M 0.31
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.40 108.28B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
762.90 79.44B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
441.00 57.65B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
902.52 56.58B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
204.32 42.39B 447.02M -1.18B -906.14M -6.1812

Innoviva Inc Stock (INVA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-30 Eingeleitet Goldman Sell
2025-08-11 Eingeleitet Oppenheimer Outperform
2025-07-14 Eingeleitet H.C. Wainwright Buy
2025-07-11 Eingeleitet Cantor Fitzgerald Overweight
2025-03-07 Eingeleitet Scotiabank Sector Outperform
2024-06-18 Eingeleitet Cantor Fitzgerald Overweight
2022-07-20 Eingeleitet Goldman Neutral
2017-11-20 Eingeleitet Deutsche Bank Hold
Alle ansehen

Innoviva Inc Aktie (INVA) Neueste Nachrichten

pulisher
Nov 21, 2025

How robust is Innoviva Inc. (HVE) stock financial positionJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Innoviva Inc. (HVE) stock outperform small cap peers2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Innoviva Inc. (HVE) stock draw ESG focused fundsJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

How buybacks impact Innoviva Inc. stock valueBond Market & Fast Entry and Exit Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Innoviva Inc. (HVE) stock trades after rate cuts2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How institutional ownership impacts Innoviva Inc. stock2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

FDA Verdict Looms: Is Zoliflodacin Poised To Transform Gonorrhea Treatment? - RTTNews

Nov 20, 2025
pulisher
Nov 20, 2025

Using data filters to optimize entry into Innoviva Inc.Portfolio Gains Summary & Real-Time Market Trend Scan - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Innoviva Inc. stock deliver better than expected guidanceJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Innoviva Inc. (HVE) stock resilient in recession scenariosWeekly Trade Analysis & Low Risk High Reward Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Innoviva Inc. stock outlook for YEARBear Alert & Fast Moving Stock Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What is the fair value estimate for Innoviva Inc. (HVE) stock in 2025Trade Signal Summary & High Win Rate Trade Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Innoviva Inc. recovery potential after sell offPortfolio Risk Summary & Growth Focused Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Innoviva Inc. still worth holding after the dipJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What sentiment indicators say about Innoviva Inc. stockVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What technical models suggest about Innoviva Inc.’s comebackWeekly Profit Summary & Weekly Momentum Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Innoviva Inc. (HVE) stock at risk of policy regulationInflation Watch & Expert Approved Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why institutional investors increase stakes in Innoviva Inc. (HVE) stockEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Innoviva Inc. stock reacts to Fed rate cutsPortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

Price-Driven Insight from (INVA) for Rule-Based Strategy - news.stocktradersdaily.com

Nov 17, 2025
pulisher
Nov 16, 2025

How Innoviva Inc. (HVE) stock reacts to stronger dollarTrade Analysis Report & Verified Swing Trading Watchlist - newser.com

Nov 16, 2025

Finanzdaten der Innoviva Inc-Aktie (INVA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Innoviva Inc-Aktie (INVA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
DENNER ALEXANDER J
10% Owner
Mar 05 '25
Sale
17.63
270,374
4,766,126
6,855,451
DENNER ALEXANDER J
10% Owner
Mar 04 '25
Sale
17.63
151,175
2,665,079
7,125,825
$39.19
price up icon 0.71%
$30.80
price up icon 1.26%
$106.12
price up icon 3.95%
$97.48
price up icon 1.98%
biotechnology ONC
$341.61
price down icon 0.47%
$204.53
price up icon 2.88%
Kapitalisierung:     |  Volumen (24h):